the reduction of lipid content of serum chylomicron , very low-density , low-density , and high-density lipoprotein fractions by the saccharin analogues indicates that these agents may be useful in controlling hyperlipidemic diseases where specific lipoprotein fractions are elevated .
C0008731
chylomicron
C0023820
lipoprotein